Washington Post: “The Biden administration is privately promising an array of liberal groups that it will wage a fierce legal battle to preserve access to abortion medication, while also developing contingency plans in case those efforts fall short.”
“One possibility is that Danco Laboratories, the manufacturer of Mifeprex, the brand-name version of mifepristone, could file a new application to have the drug approved under the standard process.”
Save to Favorites